B BRAUN FDA Approval NDA 065430

NDA 065430

B BRAUN

FDA Drug Application

Application #065430

Documents

Letter2007-08-14
Label2020-01-31
Letter2020-01-31

Application Sponsors

NDA 065430B BRAUN

Marketing Status

Prescription001
Prescription002

Application Products

001INJECTABLE;INJECTIONEQ 1GM BASE/VIAL1CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINERCEFOTETAN DISODIUM
002INJECTABLE;INJECTIONEQ 2GM BASE/VIAL1CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINERCEFOTETAN DISODIUM

FDA Submissions

UNKNOWN; ORIG1AP2007-08-09UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2013-12-18 Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
LABELING; LabelingSUPPL9AP2020-01-30STANDARD

Submissions Property Types

SUPPL6Null0
SUPPL9Null7

CDER Filings

B BRAUN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65430
            [companyName] => B BRAUN
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER","activeIngredients":"CEFOTETAN DISODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"},{"drugName":"CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER","activeIngredients":"CEFOTETAN DISODIUM","strength":"EQ 2GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"01\/30\/2020","submission":"SUPPL-9","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/065430s009lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER","submission":"CEFOTETAN DISODIUM","actionType":"EQ 1GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER","submission":"CEFOTETAN DISODIUM","actionType":"EQ 2GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2020-01-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.